| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human PIK3C2A recombinant protein (Position: R22-E1523) was used as the immunogen for the PIK3C2A antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
PIK3C2A Antibody / Phosphoinositide 3-kinase-C2-alpha is a anti-PIK3C2A Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as Western blot (WB), Immunocytochemistry (ICC), Immunofluorescence (IF), ELISA with listed reactivity in Human, Mouse. Reported localization: Cytoplasm, Nucleus, Cell membrane.
Key elements and design rationale
- Target: PIK3C2A
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): WB, ICC/IF, ELISA
Biological background
PIK3C2A contains a catalytic kinase domain, a C2 lipid-binding domain, and clathrin-binding regions that localize it to the plasma membrane and endosomes. Its enzymatic activity is essential for clathrin-mediated endocytosis and autophagosome formation. PIK3C2A also modulates signaling pathways downstream of receptor tyrosine kinases and integrins by influencing AKT activation and cytoskeletal reorganization.
The PIK3C2A antibody is widely used in cell signaling, membrane biology, and cancer research to study phosphoinositide metabolism, vesicle formation, and kinase regulation. Western blot analysis identifies a 180-190 kilodalton band corresponding to PIK3C2A, while immunofluorescence reveals punctate staining in endosomal and plasma membrane compartments. This antibody enables the analysis of lipid signaling networks that control intracellular transport and cellular morphology.
Loss or mutation of PIK3C2A has been linked to congenital cataracts, vascular defects, and impaired cilia formation due to disrupted membrane trafficking. Conversely, overexpression contributes to tumorigenesis through altered PI3K signaling and enhanced migration. The PIK3C2A antibody provides a robust tool for investigating lipid kinase function in physiology and disease.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Immunofluorescence: visualize subcellular distribution and cell-to-cell heterogeneity.
- ELISA: support antibody-based quantification in assay formats where applicable.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
